1-4 of 4
Yongli Shuai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Higher Number of Cycles of Cytarabine Consolidation Improves Outcomes in Elderly AML Patients

Asha Ricciuti, MD, Mounzer Agha, MD, Anastasios Raptis, MD, Jing-Zhou Hou, MD PhD, Rafic Farah, MD, Robert L. Redner, MD, Alison R. Sehgal, MD, Kathleen A. Dorritie, MD, James M. Rossetti, DO, Yongli Shuai, PhD, Daniel Normolle, PhD, Rahim Remtulla, MD, Shawn Tahata, MD, Michael Boyiadzis, MD, Annie Im, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4000.
https://doi.org/10.1182/blood-2018-99-113935
Published: 2018
Journal Articles

Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study

Clinical Trials & Observations
Suzanne Lentzsch, Amy O'Sullivan, Ryan C. Kennedy, Mohammad Abbas, Lijun Dai, Silvana Lalo Pregja, Steve Burt, Michael Boyiadzis, G. David Roodman, Markus Y. Mapara, Mounzer Agha, John Waas, Yongli Shuai, Daniel Normolle, Jeffrey A. Zonder
Journal: Blood
Blood (2012) 119 (20): 4608–4613.
https://doi.org/10.1182/blood-2011-12-395715
Published: 2012
Journal Articles

A Randomized Clinical Trial of Lenalidomide and Dexamethasone with and without Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma: Interim Study Results,

Lijun Dai, MD, PhD, Amy O'Sullivan, RN, BSN, Ryan Kennedy, BS, Mohammad Abbas, MD, Yongli Shuai, MS, Vida Almario Passero, MD, Carrie Andreas, PA-C, Diane Gardner, MSN, CRNP, BC, Robert L Redner, MD, G. David Roodman, MD, PhD, Stanley M. Marks, MD, Anastasios Raptis, MD, Jing-Zhou Hou, MD, PhD, Daniel Petro, MD, Min Sun, MD, PhD, Terry Evans, MD, Louis V. Pietragallo, MD, John K. Waas, DO, J. Franklin Viverette, MD, Jennifer Osborn, MD, Vincent Reyes, MD, Richard Pinkerton, DO, Theodore Crandall, MD, Ronald Fierro, MD, Robert Volkin, MD, Daniel Normolle, PhD, Markus Y. Mapara, MD, PhD, Suzanne Lentzsch, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4142.
https://doi.org/10.1182/blood.V118.21.4142.4142
Published: 2011
Journal Articles

Combination of Bendamustine, Lenalidomide, and Dexamethasone (BLD) in Patients with Refractory or Relapsed Multiple Myeloma Is Safe and Highly Effective: Results of Phase I/II Open-Label, Dose Escalation Study

Suzanne Lentzsch, MD, PhD, Amy O'Sullivan, RN, BSN, Ryan Kennedy, BS, Mohammad Abbas, MD, Navkiranjit Gill, DO, Lijun Dai, MD, PhD, Carrie Andreas, PA-C, Diane Gardner, MSN, CRNP, BC, Silvana Lalo Pregja, MBA, Steve Burt, NP, Robert L. Redner, MD, Robert Volkin, MD, G. David Roodman, MD, PhD, Markus Y. Mapara, MD, PhD, J. Franklin Viverette, MD, Mounzer Agha, MD, John K. Waas, DO, Yongli Shuai, MS, Daniel Normolle, PhD, Jeffrey A. Zonder, MD
Journal: Blood
Blood (2011) 118 (21): 304.
https://doi.org/10.1182/blood.V118.21.304.304
Published: 2011